[HTML][HTML] Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer
QQ Wang, YC Zhou, YJZ Ge, G Qin, TF Yin… - World journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND The carcinogenesis of colorectal cancer (CRC) involves many different
molecules and multiple pathways, and the specific mechanism has not been elucidated until …
molecules and multiple pathways, and the specific mechanism has not been elucidated until …
Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.
QQ Wang, YC Zhou, ZG YJ, G Qin, TF Yin… - World Journal of …, 2022 - europepmc.org
Background The carcinogenesis of colorectal cancer (CRC) involves many different
molecules and multiple pathways, and the specific mechanism has not been elucidated until …
molecules and multiple pathways, and the specific mechanism has not been elucidated until …
[HTML][HTML] Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer
QQ Wang, YC Zhou, YJZ Ge, G Qin, TF Yin… - World Journal of …, 2022 - wjgnet.com
BACKGROUND The carcinogenesis of colorectal cancer (CRC) involves many different
molecules and multiple pathways, and the specific mechanism has not been elucidated until …
molecules and multiple pathways, and the specific mechanism has not been elucidated until …
Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer
QQ Wang, YC Zhou, YJZ Ge, G Qin… - World journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The carcinogenesis of colorectal cancer (CRC) involves many different
molecules and multiple pathways, and the specific mechanism has not been elucidated until …
molecules and multiple pathways, and the specific mechanism has not been elucidated until …
Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer
QQ Wang, YC Zhou, YJZ Ge, G Qin, TF Yin… - World Journal of …, 2022 - wjgnet.com
Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic
biomarker and therapeutic target of colorectal cancer Home English English 简体中文 Sign In …
biomarker and therapeutic target of colorectal cancer Home English English 简体中文 Sign In …
Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.
QQ Wang, YC Zhou, ZG YJ, G Qin, TF Yin… - World Journal of …, 2022 - europepmc.org
Background The carcinogenesis of colorectal cancer (CRC) involves many different
molecules and multiple pathways, and the specific mechanism has not been elucidated until …
molecules and multiple pathways, and the specific mechanism has not been elucidated until …